Login
$OSTX
$1.21 -$0.04 (3.2%) Close

$OSTX SEC Filings

Filed On Filing
23 Oct 2026 D
19 Oct 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UN...

05 Oct 2026 Form 3: Clem Kerry M, Chief Commercial Officer

Holds 25,000 shares of Common Stock

05 Oct 2026 Form 3: Francis Knuettel Ii, Chief Financial Officer

Holds 20,000 shares of Common Stock

05 Oct 2026 8-K: Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers +1 more

AGREEMENT, dated as of September 29th, 2026, between OS Therapies Incorporated, a Delaware corporation (the “Company”), and Francis Knuettel II (the “Executive”).

21 Sep 2026 REGISTRATION STATEMENT
10 Sep 2026 PROSPECTUS SUPPLEMENT
10 Sep 2026 8-K: Other Events

On September 10, 2026, OS Therapies Incorporated (the “Company”) filed with the U.S. Securities and Exchange Commission (the “SEC”) a prospectus supplement (the “Prospectus Supplement”), which forms a part of the Company’s registration s...

09 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

1. Purpose. The purpose of the OS THERAPIES AMENDED AND RESTATED 2023 INCENTIVE COMPENSATION PLAN (the “Plan”) is to assist OS Therapies Incorporated, a Delaware corporation (the “Company”), and its Related Entities (as hereinafter defin...

25 Aug 2026 D
21 Aug 2026 PROSPECTUS SUPPLEMENT
21 Aug 2026 8-K: Entry into a Material Definitive Agreement
14 Aug 2026 QUARTERLY REPORT
12 Aug 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
06 Aug 2026 PROSPECTUS SUPPLEMENT
06 Aug 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
29 Jul 2026 8-K: Termination of a Material Definitive Agreement
24 Jul 2026 ARS
24 Jul 2026 DEFINITIVE ADDITIONAL MATERIALS
24 Jul 2026 Proxy statement: annual meeting on September 9, 2026

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support